Feedback / Questions
MEDI6469 - AstraZeneca
AstraZeneca: Q3 2014 Results
(AstraZeneca)
-
Nov 16, 2014 -
Anticipated completion of P1/2 trial for advanced malignancies in Q2 2016
Anticipated trial completion date
•
Oncology
http://www.astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3DClinical-trial-programmes-summary.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285682135228&ssbinary=true
Nov 16, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious